Stock PHYSIOMICS PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Physiomics Plc London S.E.

Equities

GB00B04QT956

Professional Information Services

End-of-day quote London S.E.
Other stock markets
- GBX - Intraday chart for Physiomics Plc
May. 03 Physiomics warns large contracts taken longer than expected AN
May. 03 AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal AN

Business Summary

Physiomics PLC is a United Kingdom-based company, which provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology. The Company offer its services by utilizing its proprietary Virtual Tumour predictive software, industry standard tools (such as NONMEM and MATLAB), as well as developing bespoke models using the R programming language. Virtual Tumour is a predictive quantitative systems' pharmacology (QSP) model used worldwide by global pharmaceuticals to small biotech companies to support oncology Research and development (R&D). It is a semi-mechanistic model that incorporates an abstracted representation of the cell cycle, Deoxyribonucleic acid (DNA) damage/ repair and elements of the immune response. The Company is also developing its technology for use in the field of personalized medicine. The Company is focused on helping pharma and biotech clients.

Sales per Business

GBP in Million2022Weight2023Weight Delta
Outsourced Systems and Computational Biology Services
100.0 %
1 100.0 % 1 100.0 % -28.05%

Sales per region

GBP in Million2022Weight2023Weight Delta
United Kingdom
100.0 %
1 100.0 % 1 100.0 % -28.05%

Managers

Managers TitleAgeSince
Peter Sargent CEO
 Chief Executive Officer - 23-09-04
Jim Millen CHM
 Chairman 55 16-04-17
Anthony Louis Clayden DFI
 Director of Finance/CFO 50 -
Charmaine Fraser ADM
 Chief Administrative Officer - 07-12-31
Christophe Chassagnole CTO
 Chief Tech/Sci/R&D Officer 54 04-04-30
Hayley Close PRN
 Corporate Officer/Principal - 21-08-30

Members of the board

Members of the board TitleAgeSince
Timothy Corn BRD
 Director/Board Member 73 22-03-31
Christophe Chassagnole CTO
 Chief Tech/Sci/R&D Officer 54 04-04-30
Shalabh Kumar BRD
 Director/Board Member - 22-08-31
Jim Millen CHM
 Chairman 55 16-04-17
Peter Sargent CEO
 Chief Executive Officer - 23-09-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 135,472,478 126,988,867 ( 93.74 %) 0 93.74 %

Shareholders

NameEquities%Valuation
Gary Marshall
3.322 %
4,500,000 3.322 % 73 890 p
Jim Millen
1.391 %
1,884,393 1.391 % 30 942 p
Christophe Chassagnole
0.8140 %
1,102,723 0.8140 % 18 107 p

Company contact information

Physiomics Plc

Bee House,Milton Park 140 Eastern Avenu

OX14 4SB, Oxfordshire

+44 123 5841575

http://www.physiomics-plc.com
address Physiomics Plc

Sector

Industrials
Industrial & Commercial Services
Professional & Commercial Services
Professional Information Services
Other Professional Information Services

Sector Other Professional Information Services

1st Jan change Capi.
THOMSON REUTERS CORPORATION Stock Thomson Reuters Corporation
+16.31% 74.21B
MSCI, INC. Stock MSCI, Inc.
-17.43% 37B
WOLTERS KLUWER N.V. Stock Wolters Kluwer N.V.
+11.58% 36.86B
EQUIFAX INC. Stock Equifax Inc.
-8.18% 28.07B
FACTSET RESEARCH SYSTEMS, INC. Stock FactSet Research Systems, Inc.
-10.23% 16.32B
TRANSUNION Stock TransUnion
+12.17% 14.97B
COMPUTERSHARE LIMITED Stock Computershare Limited
+8.65% 10.41B
CLARIVATE PLC Stock Clarivate Plc
-26.03% 4.58B
DUN & BRADSTREET HOLDINGS, INC. Stock Dun & Bradstreet Holdings, Inc.
-16.92% 4.3B
Other Professional Information Services
  1. Stock Market
  2. Equities
  3. PYC Stock
  4. Stock
  5. Company Physiomics Plc